Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Hutchison China MediTech Limited    HCM   KYG4672N1198

HUTCHISON CHINA MEDITECH LIMITED

(HCM)
  Report
SummaryQuotesNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Hutchison China Meditech Limited is an investment holding company principally engaged in the manufacture and sale of drugs. Along with subsidiaries, the Company operates its business through two segments. The Manufacturing Business segment is engaged in the manufacture and distribution of drug products. The Distribution Business segment provides sales and marketing services to pharmaceutical manufacturers. The Company's products include prescription and over the counter (OTC) pharmaceuticals such as banlangen, fu fang dan shen tablets and shexiang baoxin pills and others, and consumer health products. In addition, the Company also develops targeted therapeutics and immunotherapies for oncology and autoimmune diseases.

Number of employees : 853 people.
Sales per Businesses
20182019Delta
GBP (in Million)%GBP (in Million)%
Commercial Platform - Prescription Drugs99.6262%121.0975.4% +21.55%
Commercial Platform - Consumer Health30.0318.7%26.9616.8% -10.24%
Innovation Platform - Drug Research & Development30.9219.3%12.567.8% -59.38%
Sales per Regions
20182019Delta
GBP (in Million)%GBP (in Million)%
China139.5086.9%142.7388.9% +2.31%
Hong Kong21.0713.1%17.8811.1% -15.15%
Managers
NameAgeSinceTitle
Christian Hogg532006Chief Executive Officer & Executive Director
Chi Keung To672006Chairman
Enrico Magnanelli--Vice President & Head-International Operations
Chig Fung Cheng522008Chief Financial Officer & Executive Director
Wei Guo Su, Dr.612017Executive Director & Chief Scientific Officer
Marek Kania, Dr.--Senior Vice President & Senior Vice President-US
Edith Shih682006Secretary & Non-Executive Director
Dan Eldar, Dr.652016Non-Executive Director
Paul R. Carter572017Senior Independent Non-Executive Director
Karen Jean Ferrante, Dr.612017Independent Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Stock A 1 690,574,765 325,898,235 47.2% 0 0.0% 47.2%
Shareholders
NameEquities%
CK Hutchison Holdings Limited 332,478,770 48.1%
Mitsui & Co., Ltd. 33,944,020 4.92%
FIL Investment Management (Hong Kong) Ltd. 12,899,075 1.87%
Christian Hogg 11,203,320 1.62%
M&G Investment Management Ltd. 10,899,950 1.58%
Slater Investments Ltd. 3,577,600 0.52%
Capital International SARL 2,651,060 0.38%
Chig Fung Cheng 2,604,180 0.38%
Standard Life Investments Ltd. 2,553,018 0.37%
Chi Keung To 2,466,185 0.36%
Company contact information
Hutchison China MediTech Ltd.
Cheung Kong Center
2 Queen's Road Central
48th Floor
Hong Kong

Phone : +852..2128.8200
Fax : +852.2128.1778
Web : http://www.chi-med.com
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
HUTCHISON CHINA MEDITECH LIMITED-28.48%2 604
JOHNSON & JOHNSON-11.70%345 705
ROCHE HOLDING AG2.77%277 060
MERCK & CO., INC-15.48%195 141
NOVARTIS-12.10%187 703
PFIZER, INC.-16.11%181 075
NOVO NORDISK A/S5.61%141 503
BRISTOL-MYERS SQUIBB COMPANY-13.99%126 110
ELI LILLY AND COMPANY8.18%125 824
AMGEN INC.-13.35%119 572
ASTRAZENECA PLC-8.24%117 896
ABBVIE INC.-15.15%112 508
SANOFI-11.31%110 172
GLAXOSMITHKLINE-16.07%93 854
CHUGAI PHARMACEUTICAL CO., LTD.0.77%63 605
ALLERGAN PLC-7.13%58 266
JIANGSU HENGRUI MEDICINE CO., LTD.0.94%57 229
BAYER AG-27.41%57 056
TAKEDA PHARMACEUTICAL COMPANY LIMITED-2.99%47 893
DAIICHI SANKYO COMPANY, LIMITED-3.59%44 766
ASTELLAS PHARMA INC.-1.73%28 860